PTPN11 and Insulin resistance: In contrast, the fact that SHP2 hyperactivation directly promotes insulin resistance in patients with NS highlights its pathophysiological power in an integrated system that is directly relevant to human disease, and promising preclinical results have been obtained with the recently developed SHP2 inhibitors.